Chemoinformaics analysis of (3R,6E)-nerolidol
| Molecular Weight | 222.372 | nRot | 7 |
| Heavy Atom Molecular Weight | 196.164 | nRig | 3 |
| Exact Molecular Weight | 222.198 | nRing | 0 |
| Solubility: LogS | -3.897 | nHRing | 0 |
| Solubility: LogP | 5.179 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 42 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 43.1886 |
| nHD | 1 | BPOL | 26.0834 |
| QED | 0.633 |
| Synth | 3.452 |
| Natural Product Likeliness | 2.922 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.741 |
| Pgp-sub | 0.001 |
| HIA | 0.004 |
| CACO-2 | -4.496 |
| MDCK | 0.0000185 |
| BBB | 0.175 |
| PPB | 0.925219 |
| VDSS | 1.97 |
| FU | 0.0692972 |
| CYP1A2-inh | 0.377 |
| CYP1A2-sub | 0.149 |
| CYP2c19-inh | 0.622 |
| CYP2c19-sub | 0.829 |
| CYP2c9-inh | 0.244 |
| CYP2c9-sub | 0.887 |
| CYP2d6-inh | 0.217 |
| CYP2d6-sub | 0.074 |
| CYP3a4-inh | 0.746 |
| CYP3a4-sub | 0.239 |
| CL | 10.808 |
| T12 | 0.188 |
| hERG | 0.024 |
| Ames | 0.003 |
| ROA | 0.008 |
| SkinSen | 0.928 |
| Carcinogencity | 0.251 |
| EI | 0.973 |
| Respiratory | 0.015 |
| NR-Aromatase | 0.027 |
| Antiviral | Yes |
| Prediction | 0.786078 |